Correction to: Bone Marrow Transplantation (2017) 52, 704–710; doi:10.1038/bmt.2016.347; published online 9 January 2017
Since the publication of this article, the authors noticed a mistake in the text of the ‘Results’ section, in paragraph 1 underneath ‘Severity of GvHD’.
The original text was ‘At 100 days after transplantation, the cumulative incidence of grades II–IV aGvHD was 29.3% and that of grades II–IV was 4.9% (Figure 2).’
The correct text is ‘At 100 days after transplantation, the cumulative incidence of grades II–IV aGvHD was 29.3% and that of grades III–IV was 4.9% (Figure 2).’
The authors apologise for any inconvenience caused by this error.
Additional information
The online version of the original article can be found at 10.1038/bmt.2016.347
Rights and permissions
About this article
Cite this article
Liu, Z., Zhang, Y., Xiao, H. et al. Erratum: Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results. Bone Marrow Transplant 52, 1080 (2017). https://doi.org/10.1038/bmt.2017.85
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.85
This article is cited by
-
Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges
Bone Marrow Transplantation (2021)
-
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
Stem Cell Research & Therapy (2020)